China, Oct. 13 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Effect of methylene blue injection on the prognosis of septic shock patients with microvascular paralysis: an exploratory, randomized, parallel controlled clinical study'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600134206
Registration Time: 2026/10/12
Type: Interventional study
Primary Sponsor: The Third Affiliated Hospital of Southern Medical University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=329921
Published by HT Digital Content Services with permission from Health Daily Digest....